FBXL17
Basic information
Region (hg38): 5:107859035-108382098
Previous symbols: [ "FBXO13" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBXL17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 46 | 47 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 46 | 3 | 2 |
Variants in FBXL17
This is a list of pathogenic ClinVar variants found in the FBXL17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-107861763-T-C | not specified | Uncertain significance (Apr 15, 2024) | ||
5-107861847-G-A | not specified | Uncertain significance (Jan 31, 2022) | ||
5-108020943-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
5-108020997-C-T | not specified | Uncertain significance (Jan 19, 2022) | ||
5-108186179-A-G | Likely benign (Jul 16, 2018) | |||
5-108186187-T-C | not specified | Uncertain significance (Sep 06, 2022) | ||
5-108224125-G-A | not specified | Uncertain significance (Jun 21, 2022) | ||
5-108224214-T-C | Benign (May 09, 2018) | |||
5-108348416-T-C | not specified | Uncertain significance (Feb 13, 2024) | ||
5-108364772-T-C | not specified | Uncertain significance (Feb 16, 2023) | ||
5-108364821-T-A | not specified | Uncertain significance (Apr 07, 2023) | ||
5-108364912-A-G | Likely benign (Jul 16, 2018) | |||
5-108367889-C-A | not specified | Uncertain significance (Feb 17, 2023) | ||
5-108380734-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
5-108380772-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
5-108380786-C-G | not specified | Uncertain significance (Aug 15, 2023) | ||
5-108380822-C-G | not specified | Uncertain significance (Apr 07, 2022) | ||
5-108380826-G-T | not specified | Uncertain significance (Jul 09, 2021) | ||
5-108380851-C-G | not specified | Uncertain significance (Feb 27, 2023) | ||
5-108380854-G-C | not specified | Uncertain significance (Mar 31, 2022) | ||
5-108380877-G-A | not specified | Uncertain significance (Aug 12, 2022) | ||
5-108380887-C-A | not specified | Uncertain significance (Oct 03, 2022) | ||
5-108380911-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
5-108380929-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
5-108380934-T-C | not specified | Uncertain significance (Apr 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBXL17 | protein_coding | protein_coding | ENST00000542267 | 9 | 523064 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000988 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.17 | 133 | 224 | 0.593 | 0.0000116 | 4450 |
Missense in Polyphen | 17 | 68.362 | 0.24867 | 899 | ||
Synonymous | -0.882 | 90 | 80.0 | 1.13 | 0.00000401 | 1428 |
Loss of Function | 4.15 | 0 | 20.1 | 0.00 | 9.29e-7 | 340 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F- box protein)-type E3 ubiquitin ligase complex. {ECO:0000250}.;
- Pathway
- Hedgehog Signaling Pathway
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.621
- hipred
- Y
- hipred_score
- 0.572
- ghis
- 0.612
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.123
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fbxl17
- Phenotype
Gene ontology
- Biological process
- protein polyubiquitination;protein quality control for misfolded or incompletely synthesized proteins;nervous system development;regulation of smoothened signaling pathway;neural crest cell differentiation;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process
- Cellular component
- nucleus;cytoplasm;cytosol;SCF ubiquitin ligase complex
- Molecular function
- protein binding;ubiquitin protein ligase activity